A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Patients must be willing and able to complete all study-specific procedures and visits * Healthy patients, as determined by no clinically significant deviation from normal in medical history, physical examination, electrocardiogram, and clinical laboratory determinations * Body mass index (BMI) of 18 to 32 kg/m2, inclusive, at screening * Normal renal function at screening Exclusion Criteria: * History or presence of chronic bacterial, viral infection, or autoimmune disorder * Active TB requiring treatment or documented latent TB within the previous 3 years * Current or recent (within 3 months of study treatment administration) gastrointestinal disease that could affect absorption * WOCBP (women of childbearing potential) must have negative serum or urine pregnancy test.